Abstract
Abstract
Introduction
The liver has a major role in the production of coagulation factors, and cirrhotic patients have a series of coagulopathy disorders. The present study aimed to measure plasma fibrinogen levels in children with hepatic cirrhosis.
Method
Patients younger than 18 years old after diagnosis of liver cirrhosis by biopsy were enrolled in the study. Laboratory data including hemoglobin, PT, PTT, INR, and liver function tests were recorded. Fibrinogen levels were measured using the Clauss method. PELD score for children less than 12 years and MELD Na for children over 12 years were used to measure the severity of the liver disease.
Results
Fifty children with cirrhosis were studied. The mean fibrinogen level in the “PELD < 15” group was significantly higher than the other group (P < 0.001). There was no significant relationship between bleeding and fibrinogen levels. There was no significant relationship between PELD and bleeding in subjects (P = 0.87). The results of the study showed neither of these two factors (fibrinogen level and PELD) can play a predictive role in causing hemorrhage in patients.
Conclusion
Our study has shown that fibrinogen level is significantly associated with severity of liver cirrhosis and decreases with more severe disease (PELD levels), but platelet and fibrinogen cannot predict the severity of bleeding in these patients.
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference16 articles.
1. Gligorijević N, Minić S, Križáková M, Katrlik J, Nedić O (2018) Structural changes of fibrinogen as a consequence of cirrhosis. Thromb Res 166:43–49
2. El-Sayed R, El-Karaksy H, El-Raziky M, El-Hawary M, El Koofy N, Helmy H, Fahmy M (2013) Assessment of coagulation and fibrinolysis in children with chronic liver disease. Blood Coag Fibrinol 24(2):113–117
3. Kujovich JL (2015) Coagulopathy in liver disease: a balancing act. Hematology Am Soc Hematol Educ Program 2015:243–249
4. Rizzo K, Vella K, Zammit D, Gatt P, Grima C, Inguanez MB, Gerada J, Ellul P, Vassallo M, Azzopardi N (2019) Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model. Blood Transfus 17(3):237–246
5. de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR (1995) Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin (ogen) degradation products and their influence on several fibrinogen assays. Thromb Res 78(4):353–362